As tumour cell dissemination to distant sites and metastases are responsible for early patient death, we hypothesised that c-Met could be overexpressed and significantly involved in the process of IBC metastasis and that specific therapy could improve the prognosis for these patients. The gene discussed is MET; the disease is inflammatory breast carcinoma.